Mail-order abortion pill helps protect abusers and traffickers

By Dr. Calum Miller, BMBCh  As the summer of 2023 proceeds, a federal appeals court is continuing its deliberation over a lawsuit against the Food and Drug Administration (FDA) over the conditions for distribution of the abortion pill mifepristone.  At issue are an array of FDA decisions to ease access to the drug, including allowing its …

Continue reading "Mail-order abortion pill helps protect abusers and traffickers"